Inhibition profiles of human tissue kallikreins by serine protease inhibitors
-
Liu-Ying Luo
and Weiping Jiang
Abstract
Accumulated evidence has shown that human tissue kallikreins (hKs), a group of 15 homologous secreted serine proteases, are novel cancer biomarkers. We report here the inhibition profiles of selected hKs, including hK5, hK7, hK8, hK11, hK12, hK13, and hK14, by several common serine protease inhibitors (serpins) found in plasma. The association constants for the binding of serpins to kallikreins were determined and compared. Protein C inhibitor was found to be the fastest-binding serpin for most of these hKs. α2-Antiplasmin, α1-antichymotrypsin, and α1-antitrypsin also showed rapid inhibition of certain hKs. Kallistatin exhibited fast inhibition only with hK7. Our data demonstrate that these hKs are specifically regulated by certain serpins and their distinct inhibition profiles will be valuable aids in various aspects of kallikrein research.
References
Adham, I.M., Nayernia, K., and Engel, W. (1997). Spermatozoa lacking acrosin protein show delayed fertilization. Mol. Reprod. Dev.46, 370–376.10.1002/(SICI)1098-2795(199703)46:3<370::AID-MRD16>3.0.CO;2-2Search in Google Scholar
Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer4, 876–890.10.1038/nrc1474Search in Google Scholar
Chen, L.M., Chao, L., Mayfield, R.K., and Chao, J. (1990). Differential interactions of human kallikrein-binding protein and alpha 1-antitrypsin with human tissue kallikrein. Biochem. J.267, 79–84.10.1042/bj2670079Search in Google Scholar
Christensson, A. and Lilja, H. (1994). Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur. J. Biochem.220, 45–53.10.1111/j.1432-1033.1994.tb18597.xSearch in Google Scholar
Christensson, A., Laurell, C.B., and Lilja, H. (1990). Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem.194, 755–763.10.1111/j.1432-1033.1990.tb19466.xSearch in Google Scholar
Deperthes, D., Chapdelaine, P., Tremblay, R.R., Brunet, C., Berton, J., Hebert, J., Lazure, C., and Dube, J.Y. (1995). Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim. Biophys. Acta1245, 311–316.10.1016/0304-4165(95)00118-2Search in Google Scholar
Ecke, S., Geiger, M., and Binder, B.R. (1997). Heparin binding of protein-C inhibitor – analysis of the effect of heparin on the interaction of protein-C inhibitor with tissue kallikrein. Eur. J. Biochem.248, 475–480.10.1111/j.1432-1033.1997.00475.xSearch in Google Scholar
Espana, F., Fink, E., Sanchez-Cuenca, J., Gilabert, J., Estelles, A., and Witzgall, K. (1995). Complexes of tissue kallikrein with protein C inhibitor in human semen and urine. Eur. J. Biochem.234, 641–649.10.1111/j.1432-1033.1995.641_b.xSearch in Google Scholar
Hermans, J.M., Jones, R., and Stone, S.R. (1994). Rapid inhibition of the sperm protease acrosin by protein C inhibitor. Biochemistry33, 5440–5444.10.1021/bi00184a012Search in Google Scholar
Kapadia, C., Chang, A., Sotiropoulou, G., Yousef, G.M., Grass, L., Soosaipillai, A,, Xing, X., Howarth, D.H., and Diamandis, E.P. (2003). Human kallikrein 13, production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay. Clin. Chem.49, 77–86.10.1373/49.1.77Search in Google Scholar
Klemm, U., Müller-Esterl, W., and Engel, W. (1991). Acrosin, the peculiar sperm-specific serine protease. Hum. Genet.87, 635–641.10.1007/BF00201716Search in Google Scholar
Laurell, M., Christensson, A., Abrahamsson, P.A., Stenflo, J., and Lilja, H. (1992). Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J. Clin. Invest.89, 1094–1101.Search in Google Scholar
Lovgren, J., Airas, K., and Lilja, H. (1999). Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors. Eur. J. Biochem.262, 781–789.Search in Google Scholar
Mikolajczyk, S.D., Millar, L.S., Kumar, A., and Saedi, M.S. (1998). Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors. Prostate34, 44–50.10.1002/(SICI)1097-0045(19980101)34:1<44::AID-PROS6>3.0.CO;2-KSearch in Google Scholar
Mikolajczyk, S.D., Millar, L.S., Kumar, A., and Saedi, M.S. (1999). Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1. Int. J. Cancer81, 438–442.10.1002/(SICI)1097-0215(19990505)81:3<438::AID-IJC18>3.0.CO;2-USearch in Google Scholar
Rahman, M.M., Worthy, K., Elson, C.J., Fink, E., Dieppe, P.A., and Bhoola, K.D. (1994). Inhibitor regulation of tissue kallikrein activity in the synovial fluid of patients with rheumatoid arthritis. Br. J. Rheumatol.33, 215–223.10.1093/rheumatology/33.3.215Search in Google Scholar
Salvesen, G.S. and Nagase, H. (2001). Inhibition of proteolytic enzymes. In: Proteolytic Enzymes, R. Beynon and J.S. Bond, eds. (Oxford, UK: Oxford University Press), pp. 105–147.Search in Google Scholar
Silverman, G.A., Bird, P.I., Carrell, R.W., Church, F.C., Coughlin, P.B., Gettins, P.G., Irving, J.A., Lomas, D.A., Luke, C.J., Moyer, R.W., et al. (2001). The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem.276, 33293–33296.10.1074/jbc.R100016200Search in Google Scholar
Stenman, U.H., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K., and Alfthan, O. (1991). A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res.51, 222–226.Search in Google Scholar
Travis, J. and Salvesen, G.S. (1983). Human plasma proteinase inhibitors. Annu. Rev. Biochem.52, 655–709.10.1146/annurev.bi.52.070183.003255Search in Google Scholar
Uhrin, P., Dewerchin M., Hilpert, M., Chrenek, P., Schofer, C., Zechmeister-Manchhart, M., Kronke, G., Vales A., Carmeliet, P., Binder, B.P., and Geiger, M. (2000). Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility. J. Clin. Invest.106, 1531–1539.10.1172/JCI10768Search in Google Scholar
Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family, structure, function, and association to disease. Endocr. Rev.22, 184–204.Search in Google Scholar
Yousef, G.M., Polymeris, M.E., Grass, L., Soosaipillai, A., Chan, P.C., Scorilas, A., Borgono, C., Harbeck, N., Schmalfeldt, B., Dorn, J., et al. (2003). Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Cancer Res.63, 3958–3965.Search in Google Scholar
Zhou, G.X., Chao, L., and Chao, J. (1992). Kallistatin, a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence. J. Biol. Chem.267, 25873–25880.Search in Google Scholar
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- The First International Symposium on Kallikreins
- A comprehensive nomenclature for serine proteases with homology to tissue kallikreins
- The kallikrein world: an update on the human tissue kallikreins
- Cellular distribution of human tissue kallikreins: immunohistochemical localization
- The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction
- Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more
- Recombinant kallikrein expression: site-specific integration for hK6 production in human cells
- Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?
- The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition
- Human kallikrein 10, a predictive marker for breast cancer
- Activation and enzymatic characterization of recombinant human kallikrein 8
- Human tissue kallikrein 9: production of recombinant proteins and specific antibodies
- The human kallikrein 10 promoter contains a functional retinoid response element
- Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins
- Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum
- A sensitive proximity ligation assay for active PSA
- Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer
- Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues
- mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy
- The epigenetic basis for the aberrant expression of kallikreins in human cancers
- Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network
- Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells
- Inhibition profiles of human tissue kallikreins by serine protease inhibitors
- Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs)
Articles in the same Issue
- The First International Symposium on Kallikreins
- A comprehensive nomenclature for serine proteases with homology to tissue kallikreins
- The kallikrein world: an update on the human tissue kallikreins
- Cellular distribution of human tissue kallikreins: immunohistochemical localization
- The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction
- Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more
- Recombinant kallikrein expression: site-specific integration for hK6 production in human cells
- Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?
- The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition
- Human kallikrein 10, a predictive marker for breast cancer
- Activation and enzymatic characterization of recombinant human kallikrein 8
- Human tissue kallikrein 9: production of recombinant proteins and specific antibodies
- The human kallikrein 10 promoter contains a functional retinoid response element
- Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins
- Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum
- A sensitive proximity ligation assay for active PSA
- Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer
- Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues
- mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy
- The epigenetic basis for the aberrant expression of kallikreins in human cancers
- Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network
- Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells
- Inhibition profiles of human tissue kallikreins by serine protease inhibitors
- Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs)